Associate, Atlas Venture
Dr. Hakan Goker is an Associate in the life sciences group of Atlas Venture and joined the firm in 2006.
Hakan is responsible for new deals from deal origination to funding in drug development, medical device and diagnostic companies outside the US. He helps manage the Atlas European portfolio companies with particular focus on Bicycle Therapeutics, f-Star, Nitec Pharma (now Horizon) and Lumavita.
Previously, he worked as a Postdoctoral Fellow at the Institute of Cancer Research / Royal Marsden Hospital and the Breakthrough Breast Cancer Centre in the fields of cancer and development.
Hakan holds a BSc (Hons) in Human Genetics from University College London. He obtained his PhD for his work in molecular biology focusing in cancer at University of London's Institute of Cancer Research. Hakan has authored and co-authored publications in leading scientific journals, including Oncogene and the British Journal of Cancer. Hakan is a British Chevening and a Fulbright scholar.